A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 41
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MNV
Long Form : mean nuclear volume
No. Year Title Co-occurring Abbreviation
2014 Advantages of evaluating mean nuclear volume as an adjunct parameter in prostate cancer. Gpp, GSc, PCa, PSA
2010 Mean nuclear volume in complex atypical hyperplasia and adenocarcinoma of the endometrium. CAH, WDAC
2005 Risk stratification after radical prostatectomy in men with pathologically organ-confined prostate cancer using volume-weighted mean nuclear volume. PC, RP
2004 Impact of volume weighted mean nuclear volume on outcomes following salvage radiation therapy after radical prostatectomy. PSA, RP, RT
2004 Mean nuclear volume in ovarian papillary serous cystadenocarcinoma. FIGO
2004 Mean nuclear volume in squamous cell carcinoma of the vulva. ---
2004 Utility of mean nuclear volume in predicting disease-free survival in locally advanced invasive cervical squamous cell carcinoma. DFS
2002 Mean nuclear volume in cervical intraepithelial neoplasia and carcinoma. CIN
2001 Volume-weighted mean nuclear volume predicts tumor biology of clinically organ-confined prostate cancer. PSA, PSADT
10  2000 Analysis of the mechanism of discrepant nuclear morphometric results comparing preoperative biopsy and prostatectomy specimens. BPH, FF, MNA
11  2000 Prognosis of primary testicular seminoma: a report on 57 new cases. AFP, ALP, beta-hCG, LDH
12  2000 Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer: is volume-weighted mean nuclear volume superior to other morphometric parameters? VNA
13  2000 The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases. ---
14  2000 Volume-weighted mean nuclear volume. Is this new prognosticator comparable in different institutions? SCH, SMH, SPH
15  1999 Comparison of nuclear morphometric results between needle biopsy and surgical specimens from patients with prostate cancer. FF, MNA
16  1999 Ki-67 immunostaining and stereologic estimation of nuclear volume in melanocytic skin tumors. CN, PMM
17  1999 Mean nuclear volume: a supplementary prognostic factor in endometrial cancer. DEMCA, P-stage
18  1999 Prognostic value of sarcomatoid histology and volume-weighted mean nuclear volume in renal cell carcinoma. RCC
19  1999 The role of volume-weighted mean nuclear volume in predicting disease outcome in patients with prostate cancer treated with radical prostatectomy. GS
20  1999 The role of volume-weighted mean nuclear volume in predicting disease outcome in patients with stage M1 prostate cancer. GS, PSA
21  1999 Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma. RCC, TNM
22  1998 Combining volume-weighted mean nuclear volume with Gleason score and clinical stage to predict more reliably disease outcome of patients with prostate cancer. PI
23  1998 Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment. HR, MNA
24  1998 Volume-weighted mean nuclear volume in renal cell carcinoma. RCC
25  1997 Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder. LI, NRF, PCNA
26  1997 Intratumoral heterogeneity in prostate cancer demonstrated by volume-weighted mean nuclear volume. ---
27  1997 Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume. GS
28  1997 Stereologically estimated mean nuclear volume of prostatic cancer is a reliable prognostic parameter. WHO
29  1996 Stereological evaluation of malignant mesothelioma versus benign pleural hyperplasia. PSI
30  1996 [A morphological study of renal adenoma and latent renal cell carcinoma in autopsy cases]. MNA, NRF
31  1996 [Prognostic criteria in patients with renal pelvic and ureteral cancers--clinical value of volume weighted mean nuclear volume]. WHO
32  1995 Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma. NRF, VNA
33  1995 Prognostic criteria in patients with stage D2 prostate cancer. Correlation with mean nuclear volume. GS, WHO
34  1995 [Prognostic factor in patients with prostate cancer]. GS, JUA, TURP
35  1994 [The prognostic value of mean nuclear area and mean nuclear volume in bladder cancer]. MNA
36  1993 Histological grade, DNA ploidy and mean nuclear volume as prognostic factors in prostatic cancer. ---
37  1992 Nuclear volume and prognosis in ovarian cancer. ---
38  1992 [Clinical significance of stereological estimation of mean nuclear volume in human bladder carcinoma--further analysis of nuclear morphometric variables]. MNA, NRF, VNA
39  1992 [Clinical significance of the stereological estimation of mean nuclear volume in human bladder carcinoma--relation to tumor grade, stage and prognosis]. ---
40  1991 [Estimation of nuclear volume of nontumorous bladder mucosa in patients with bladder tumor--measurement by vertical section]. CIS
41  1984 Inhibitory action of the pineal gland on the nuclear volume of thyroid follicular cells in male gerbils (Meriones unguiculatus). LPP, SPP